[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Artivion Inc (AORT)

Artivion Inc (AORT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,232,283
  • Shares Outstanding, K 48,496
  • Annual Sales, $ 441,330 K
  • Annual Income, $ 9,770 K
  • EBIT $ 34 M
  • EBITDA $ 56 M
  • 60-Month Beta 1.41
  • Price/Sales 3.89
  • Price/Cash Flow 32.15
  • Price/Book 3.74

Options Overview Details

View History
  • Implied Volatility 57.05% (-3.54%)
  • Historical Volatility 105.11%
  • IV Percentile 40%
  • IV Rank 7.51%
  • IV High 343.80% on 11/28/25
  • IV Low 33.76% on 08/12/25
  • Expected Move (DTE 4) 0.72 (2.84%)
  • Put/Call Vol Ratio 0.29
  • Today's Volume 44
  • Volume Avg (30-Day) 6
  • Put/Call OI Ratio 0.13
  • Today's Open Interest 142
  • Open Int (30-Day) 149
  • Expected Range 24.69 to 26.13

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $0.13
  • Number of Estimates 1
  • High Estimate $0.13
  • Low Estimate $0.13
  • Prior Year $0.24
  • Growth Rate Est. (year over year) -45.83%

Price Performance

See More
Period Period Low Period High Performance
1-Month
19.16 +36.06%
on 05/08/26
39.66 -34.27%
on 04/21/26
-11.56 (-30.72%)
since 04/10/26
3-Month
19.16 +36.06%
on 05/08/26
40.93 -36.31%
on 02/12/26
-14.03 (-34.99%)
since 02/11/26
52-Week
19.16 +36.06%
on 05/08/26
48.25 -45.97%
on 12/17/25
-2.84 (-9.82%)
since 05/09/25

Most Recent Stories

More News
Artivion Q1 Earnings Call Highlights

Artivion (NYSE:AORT) executives said the company delivered double-digit revenue and adjusted EBITDA growth in the first quarter of 2026, while also lowering its full-year revenue outlook due primarily...

AORT : 25.02 (-1.53%)
Why Artivion (AORT) Stock Is Falling Today

Why Artivion (AORT) Stock Is Falling Today

AORT : 25.02 (-1.53%)
AORT Q1 Deep Dive: Guidance Reset and Product Launches Shape 2026 Outlook

AORT Q1 Deep Dive: Guidance Reset and Product Launches Shape 2026 Outlook

AORT : 25.02 (-1.53%)
Artivion: Q1 Earnings Snapshot

Artivion: Q1 Earnings Snapshot

AORT : 25.02 (-1.53%)
Artivion’s (NYSE:AORT) Q1 CY2026 Earnings Results: Revenue In Line With Expectations

Artivion’s (NYSE:AORT) Q1 CY2026 Earnings Results: Revenue In Line With Expectations

AORT : 25.02 (-1.53%)
Artivion Reports First Quarter 2026 Financial Results and Announces Exercise of Option to Acquire Endospan

First Quarter & Recent Business Highlights:

AORT : 25.02 (-1.53%)
What To Expect From Artivion’s (AORT) Q1 Earnings

What To Expect From Artivion’s (AORT) Q1 Earnings

AORT : 25.02 (-1.53%)
3 Reasons to Avoid AORT and 1 Stock to Buy Instead

3 Reasons to Avoid AORT and 1 Stock to Buy Instead

AORT : 25.02 (-1.53%)
Artivion Announces Release Date and Teleconference Call Details for First Quarter 2026 Financial Results

ATLANTA , April 23, 2026 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, announced today that first quarter 2026 financial...

AORT : 25.02 (-1.53%)
1 Stock Under $50 to Own for Decades and 2 We Avoid

1 Stock Under $50 to Own for Decades and 2 We Avoid

BOX : 25.70 (-0.08%)
WT : 19.19 (+0.47%)
AORT : 25.02 (-1.53%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

Relative Strength is below 30%. The market is in oversold territory. Watch for a potential trend reversal.

See More Share

Business Summary

Artivion Inc. is a medical device company. It focused on developing simple, elegant solutions which address cardiac and vascular surgeons. The company's group of products include aortic stents and stent grafts, prosthetic heart valves, cryopreserved cardiac and vascular allografts and surgical sealants....

See More

Key Turning Points

3rd Resistance Point 36.91
2nd Resistance Point 32.11
1st Resistance Point 28.76
Last Price 25.02
1st Support Level 20.61
2nd Support Level 15.81
3rd Support Level 12.46

See More

52-Week High 48.25
Fibonacci 61.8% 37.14
Fibonacci 50% 33.71
Fibonacci 38.2% 30.27
Last Price 25.02
52-Week Low 19.16

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.